Hilgert I, Kinsky R G
Folia Biol (Praha). 1983;29(5):349-57.
The purpose of the present work was to examine the persistence of regulatory cells implicated in the inhibition of allotransplantation reactions in recipient mice in the absence of antigenic material. Two experimental systems were used: (1) When neonatally induced tolerance (obtained as a result of cell-free spleen extract administration in the B10.D2 versus M504 strain combination) was adoptively transferred, the persistence of suppressor cells was detected in secondary recipients receiving a second homograft as long as 30 days after removal of a first homograft to the tolerance inducing haplotype. The removal of the skin homograft presenting a source of antigen for 60 days, resulted in tolerance interruption when a second test graft was applied. (2) When tolerance was induced in CBA mice with spleen-cell antigenic extracts and CFA and spleen cells from such animals were transferred to secondary recipients the following results were observed: Secondary recipients grafted with SaI tumour cells derived from the tolerance inducing A strain 20 days after tolerance induction presented an enhanced tumour growth. The adoptive transfer of this effect was at least partly due to IJ+ lymphocytes, since their removal reduced adoptive enhancement. However, if the cell transfer was delayed for 56 days after tolerance induction, the depletion of IJ+ or Thy 1.2+ cells did not affect the capacity of spleen cells to cause an enhanced growth of the homografted SaI cells. A delay of 100 days following donor enhancement induction did not result any adoptive transfer of SaI enhancement.
本研究的目的是在缺乏抗原物质的情况下,检测受体小鼠中参与抑制同种异体移植反应的调节性细胞的持久性。使用了两个实验系统:(1)当采用新生诱导耐受(通过在B10.D2与M504品系组合中给予无细胞脾提取物获得)进行过继转移时,在接受第二次同种异体移植的二级受体中检测到抑制性细胞的持久性,在向诱导耐受的单倍型移植第一个同种异体移植物后长达30天。去除作为抗原来源的皮肤同种异体移植物60天,当应用第二个测试移植物时导致耐受中断。(2)当用脾细胞抗原提取物和CFA在CBA小鼠中诱导耐受并将来自此类动物的脾细胞转移到二级受体时,观察到以下结果:在耐受诱导后20天用源自诱导耐受的A品系的SaI肿瘤细胞移植的二级受体呈现出增强的肿瘤生长。这种效应的过继转移至少部分归因于IJ +淋巴细胞,因为去除它们会降低过继增强作用。然而,如果在耐受诱导后56天延迟细胞转移,IJ +或Thy 1.2 +细胞的耗竭不会影响脾细胞导致同种异体移植的SaI细胞生长增强的能力。在供体增强诱导后延迟100天不会导致SaI增强的任何过继转移。